A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,744,805 shares of GOSS stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,744,805
Previous 2,046,600 14.75%
Holding current value
$1.22 Million
Previous $1.84 Million 6.19%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.79 - $1.25 $238,418 - $377,243
-301,795 Reduced 14.75%
1,744,805 $1.73 Million
Q2 2024

Aug 09, 2024

BUY
$0.51 - $1.27 $701,250 - $1.75 Million
1,375,000 Added 204.73%
2,046,600 $1.84 Million
Q1 2024

May 13, 2024

SELL
$0.8 - $1.51 $260,320 - $491,355
-325,401 Reduced 32.64%
671,600 $792,000
Q4 2023

Feb 13, 2024

BUY
$0.48 - $1.08 $478,560 - $1.08 Million
997,001 New
997,001 $910,000
Q3 2022

Nov 14, 2022

SELL
$7.21 - $14.88 $238,651 - $492,528
-33,100 Reduced 48.04%
35,800 $429,000
Q2 2022

Aug 12, 2022

SELL
$5.97 - $9.97 $377,304 - $630,104
-63,200 Reduced 47.84%
68,900 $577,000
Q1 2022

May 13, 2022

BUY
$8.44 - $12.49 $746,096 - $1.1 Million
88,400 Added 202.29%
132,100 $1.15 Million
Q4 2021

Feb 11, 2022

BUY
$10.12 - $14.07 $442,243 - $614,859
43,700 New
43,700 $494,000
Q2 2021

Aug 13, 2021

SELL
$8.0 - $9.75 $1.2 Million - $1.46 Million
-150,000 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$8.63 - $10.94 $283,064 - $358,832
-32,800 Reduced 17.94%
150,000 $1.39 Million
Q4 2020

Feb 10, 2021

SELL
$8.3 - $13.59 $1.27 Million - $2.08 Million
-152,800 Reduced 45.53%
182,800 $1.77 Million
Q3 2020

Nov 13, 2020

SELL
$11.3 - $14.75 $316,400 - $413,000
-28,000 Reduced 7.7%
335,600 $4.17 Million
Q2 2020

Aug 13, 2020

BUY
$9.52 - $15.98 $2.53 Million - $4.25 Million
266,138 Added 273.07%
363,600 $4.73 Million
Q1 2020

May 14, 2020

BUY
$8.0 - $15.48 $779,696 - $1.51 Million
97,462 New
97,462 $989,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $65.8M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.